SMEK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.527800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.062800E-01
Normal-vs-Stage2
4.667400E-01
Normal-vs-Stage3
2.347000E-01
Normal-vs-Stage4
7.245200E-01
Stage1-vs-Stage2
9.706000E-01
Stage1-vs-Stage3
1.124790E-01
Stage1-vs-Stage4
4.711800E-01
Stage2-vs-Stage3
6.320000E-02
Stage2-vs-Stage4
2.861600E-01
Stage3-vs-Stage4
9.408200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.574200E-01
Normal-vs-AfricanAmerican
3.366800E-01
Normal-vs-Asian
1.709620E-01
Caucasian-vs-AfricanAmerican
9.558800E-01
Caucasian-vs-Asian
3.499200E-01
AfricanAmerican-vs-Asian
6.749400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.589800E-01
Normal-vs-Female
8.742300E-02
Male-vs-Female
8.568400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.161600E-01
Normal-vs-Age(41-60Yrs)
5.637400E-01
Normal-vs-Age(61-80Yrs)
6.573800E-02
Normal-vs-Age(81-100Yrs)
1.015000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.934800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.690000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.093600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.158200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.153700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.412400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.938000E-02
Normal-vs-Daily Drinker
5.000000E-02
Normal-vs-Weekly Drinker
1.330580E-01
Normal-vs-Occasional Drinker
5.327800E-01
Normal-vs-Social Drinker
2.084000E-01
Non Drinker-vs-Daily Drinker
6.232600E-01
Non Drinker-vs-Weekly Drinker
9.269200E-01
Non Drinker-vs-Occasional Drinker
1.473800E-01
Non Drinker-vs-Social Drinker
2.967400E-01
Daily Drinker-vs-Weekly Drinker
7.637000E-01
Daily Drinker-vs-Occasional Drinker
5.712300E-02
Daily Drinker-vs-Social Drinker
1.518440E-01
Weekly Drinker-vs-Occasional Drinker
1.955640E-01
Weekly Drinker-vs-Social Drinker
3.538200E-01
Occasional Drinker-vs-Social Drinker
8.045000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.781700E-02
Normal-vs-Grade 2
5.203200E-03
Normal-vs-Grade 3
1.849510E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.928800E-01
Grade 1-vs-Grade 3
4.041200E-01
Grade 1-vs-Grade 4
7.781700E-02
Grade 2-vs-Grade 3
5.895400E-01
Grade 2-vs-Grade 4
5.203200E-03
Grade 3-vs-Grade 4
1.849510E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.863400E-01
Normal-vs-NonDiabetic
4.308000E-01
Diabetic-vs-NonDiabetic
4.087000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.706000E-01
Normal-vs-NoPancreatitis
4.373200E-01
Pancreatitis-vs-NoPancreatitis
2.358100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.622100E-02
Normal-vs-N1
4.816600E-01
N0-vs-N1
1.566250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.615400E-01
Normal-vs-TP53-NonMutant
2.610600E-01
TP53-Mutant-vs-TP53-NonMutant
9.068800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
